Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.

By A. Lukyanov, Vladimir Torchilin. Advanced Drug Delivery Reviews, 2004

629 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability (2014, methodology): “…polymer shell and B being the hydrophobic polymer core) or an A-B-A multi-block structure of co-polymers of different hydrophobicity or a graft co-polymer (hydrophilic backbone chain of a polymer grafted with hydrophobic blocks) asian journal of pharmaceutical sciences 9 (2014) 304 e 316 [65,66].”
In situ forming implants - an attractive formulation principle for parenteral depot formulations. (2012, background): “Various types of parenteral dosage forms are available, such as solutions, emulsions [2], liposomes [3], micelles [4], implants [5], microparticles [6], nanoparticles and nanocapsules [7].”
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, methodology): “Drugs can be loaded into PEG-PE micelles by simply mixing PEG-PE conjugates and a drug of interest in a miscible volatile organic solvent and evaporating the solvent to form a dry PEG-PE film containing the appropriate drug (Lukyanov and Torchilin, 2004).”